Lessons learned in nutrition therapy in patients with severe COVID-19
The coronavirus disease 2019 (COVID‐19) pandemic has reached worldwide, and until a vaccine is found, it will continue to cause significant morbidity and mortality. The clinical presentation of COVID‐19 ranges from that of being asymptomatic to developing a fatal illness characterized by multiple or...
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | Colombia |
| Institución: | Universidad El Bosque |
| Repositorio: | Repositorio U. El Bosque |
| Idioma: | inglés |
| OAI Identifier: | oai:repositorio.unbosque.edu.co:20.500.12495/5498 |
| Acceso en línea: | http://hdl.handle.net/20.500.12495/5498 https://doi.org/10.1002/jpen.2005 |
| Access Level: | acceso abierto |
| Palabra clave: | COVID‐19 Hypocaloric Nutrition Obesity Protein |
| id |
CO_f837fe8b366a8a8a0cea7f130f4e3bcd |
|---|---|
| oai_identifier_str |
oai:repositorio.unbosque.edu.co:20.500.12495/5498 |
| network_acronym_str |
CO |
| network_name_str |
Colombia |
| repository_id_str |
|
| spelling |
Lessons learned in nutrition therapy in patients with severe COVID-19Lessons learned in nutrition therapy in patients with severe COVID-19Ochoa, Juan B.Cárdenas, DianaGoiburu, María E.Bermúdez, CharlesCarrasco, FernandoCorreia, M. Isabel T. D.COVID‐19HypocaloricNutritionObesityProteinThe coronavirus disease 2019 (COVID‐19) pandemic has reached worldwide, and until a vaccine is found, it will continue to cause significant morbidity and mortality. The clinical presentation of COVID‐19 ranges from that of being asymptomatic to developing a fatal illness characterized by multiple organ involvement. Approximately 20% of the patients will require hospitalization; one‐quarter of hospitalized patients will develop severe COVID‐19 requiring admission to the intensive care unit, most frequently, with acute respiratory failure. An ongoing effort is being made to identify the patients that will develop severe COVID‐19. Overall, patients present with 3 different phenotypes of nutrition risk: (1) the frail older patient, (2) the patient with severe ongoing chronic illness, and (3) the patient with severe and morbid obesity. These 3 phenotypes represent different nutrition risks and diverse nutrition interventions. This article explores the different potential approaches to nutrition intervention in patients with COVID‐19, evaluating, in this process, the challenges faced in the implementation of guidelines written by different societies.WileyJournal of Parenteral and Enteral Nutrition2021-03-02T14:33:34Z2021-03-02T14:33:34ZArtículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfapplication/pdf1941-2444http://hdl.handle.net/20.500.12495/5498https://doi.org/10.1002/jpen.2005instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coengJournal of Parenteral and Enteral Nutrition, 1941-2444, Vol. 44, No. 8, 2020, p. 1369-1375https://onlinelibrary.wiley.com/doi/full/10.1002/jpen.2005Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2020-08-24reponame:Repositorio U. El Bosqueinstname:Universidad El Bosqueinstacron:Universidad El Bosque2022-05-03T02:11:09Z |
| dc.title.none.fl_str_mv |
Lessons learned in nutrition therapy in patients with severe COVID-19 Lessons learned in nutrition therapy in patients with severe COVID-19 |
| title |
Lessons learned in nutrition therapy in patients with severe COVID-19 |
| spellingShingle |
Lessons learned in nutrition therapy in patients with severe COVID-19 Ochoa, Juan B. COVID‐19 Hypocaloric Nutrition Obesity Protein |
| title_short |
Lessons learned in nutrition therapy in patients with severe COVID-19 |
| title_full |
Lessons learned in nutrition therapy in patients with severe COVID-19 |
| title_fullStr |
Lessons learned in nutrition therapy in patients with severe COVID-19 |
| title_full_unstemmed |
Lessons learned in nutrition therapy in patients with severe COVID-19 |
| title_sort |
Lessons learned in nutrition therapy in patients with severe COVID-19 |
| dc.creator.none.fl_str_mv |
Ochoa, Juan B. Cárdenas, Diana Goiburu, María E. Bermúdez, Charles Carrasco, Fernando Correia, M. Isabel T. D. |
| author |
Ochoa, Juan B. |
| author_facet |
Ochoa, Juan B. Cárdenas, Diana Goiburu, María E. Bermúdez, Charles Carrasco, Fernando Correia, M. Isabel T. D. |
| author_role |
author |
| author2 |
Cárdenas, Diana Goiburu, María E. Bermúdez, Charles Carrasco, Fernando Correia, M. Isabel T. D. |
| author2_role |
author author author author author |
| dc.subject.none.fl_str_mv |
COVID‐19 Hypocaloric Nutrition Obesity Protein |
| topic |
COVID‐19 Hypocaloric Nutrition Obesity Protein |
| description |
The coronavirus disease 2019 (COVID‐19) pandemic has reached worldwide, and until a vaccine is found, it will continue to cause significant morbidity and mortality. The clinical presentation of COVID‐19 ranges from that of being asymptomatic to developing a fatal illness characterized by multiple organ involvement. Approximately 20% of the patients will require hospitalization; one‐quarter of hospitalized patients will develop severe COVID‐19 requiring admission to the intensive care unit, most frequently, with acute respiratory failure. An ongoing effort is being made to identify the patients that will develop severe COVID‐19. Overall, patients present with 3 different phenotypes of nutrition risk: (1) the frail older patient, (2) the patient with severe ongoing chronic illness, and (3) the patient with severe and morbid obesity. These 3 phenotypes represent different nutrition risks and diverse nutrition interventions. This article explores the different potential approaches to nutrition intervention in patients with COVID‐19, evaluating, in this process, the challenges faced in the implementation of guidelines written by different societies. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021-03-02T14:33:34Z 2021-03-02T14:33:34Z |
| dc.type.none.fl_str_mv |
Artículo de revista info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
1941-2444 http://hdl.handle.net/20.500.12495/5498 https://doi.org/10.1002/jpen.2005 instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque repourl:https://repositorio.unbosque.edu.co |
| identifier_str_mv |
1941-2444 instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque repourl:https://repositorio.unbosque.edu.co |
| url |
http://hdl.handle.net/20.500.12495/5498 https://doi.org/10.1002/jpen.2005 |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
Journal of Parenteral and Enteral Nutrition, 1941-2444, Vol. 44, No. 8, 2020, p. 1369-1375 https://onlinelibrary.wiley.com/doi/full/10.1002/jpen.2005 |
| dc.rights.none.fl_str_mv |
Acceso abierto http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Acceso abierto 2020-08-24 |
| rights_invalid_str_mv |
Acceso abierto http://purl.org/coar/access_right/c_abf2 2020-08-24 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Wiley Journal of Parenteral and Enteral Nutrition |
| publisher.none.fl_str_mv |
Wiley Journal of Parenteral and Enteral Nutrition |
| dc.source.none.fl_str_mv |
reponame:Repositorio U. El Bosque instname:Universidad El Bosque instacron:Universidad El Bosque |
| instname_str |
Universidad El Bosque |
| instacron_str |
Universidad El Bosque |
| institution |
Universidad El Bosque |
| reponame_str |
Repositorio U. El Bosque |
| collection |
Repositorio U. El Bosque |
| _version_ |
1825051200402227200 |
| score |
15.812455 |